News
04-19-2010, 11:20 AM
The STAR trial suggest that tamoxifen lowers breast cancer risk by 50 percent, compared with 38 percent for Evista.
More... (http://www.healthcentral.com/breast-cancer/news-515096-98.html)
More... (http://www.healthcentral.com/breast-cancer/news-515096-98.html)